Narrative review / 2019
Plant sterols and stanols may exert broader physiological and clinical effects beyond lowering low-density lipoprotein cholesterol.
This review evaluates potential biological roles and health effects of plant sterols and stanols beyond their known inhibition of intestinal cholesterol absorption and LDL lowering. The authors examine impacts ranging from intrauterine presence and breast milk to conditions such as non-alcoholic steatohepatitis, cardiovascular disease, inflammatory bowel diseases, and allergic asthma. Effects also appear to depend on the route of administration, as seen in intestinal-failure associated liver disease during parenteral nutrition. The authors emphasize a need to systematically understand the broader health effects of these compounds.
- Study type
- Narrative review
- Who was studied
- Humans across development (including intrauterine, breast milk, and clinical contexts)
- What was measured
- Health effects beyond cholesterol lowering, including NASH, CVD, IBD, asthma, and IFALD
THE PAPER
Plant-based sterols and stanols in health & disease: "Consequences of human development in a plant-based environment?".
Plat J, Baumgartner S, Vanmierlo T, Lütjohann D, Calkins KL, Burrin DG, Guthrie G, Thijs C, Te Velde AA, Vreugdenhil ACE, Sverdlov R, Garssen J, Wouters K, Trautwein EA, Wolfs TG, van Gorp C, Mulder MT, Riksen NP, Groen AK, Mensink RP. Prog Lipid Res, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.